Home » Healthcare » Pharmaceuticals » Plasma Protein Therapeutics Market

Plasma Protein Therapeutics Market – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: | Report ID: 9800 | Report Format : PDF

Market Insights

A variety of life-threatening and chronic disorders, such as hematological diseases, immune deficiencies, genetic diseases, and neurological disorders, among others, are treated with plasma proteins. The different clinical responses of plasma proteins are due to their unique biochemical profile and variances in production and processing technologies. Recent developments observed in the plasma protein therapeutics industry are satisfactory and ground-breaking, especially the recently approved recombinant protein therapeutics, which cater to several clinical indications such as autoimmune diseases, cancers, infectious diseases, and genetic disorders.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

These advancements in plasma protein therapeutics technologies have enabled industry players to maximize the therapeutic potential of proteins while maintaining product safety and efficacy. The key factors driving this market are the huge applications of immunoglobulins and albumin, which cater to a wide range of diseases; rising investment in research and development of novel plasma protein-based drugs; and increasing off-label use of immunoglobulins.

The global regulatory framework is evolving day by day with the incessant development of novel technologies in the biopharmaceutical industry. In the case of plasma protein therapeutics, improved versions of current therapies are being introduced that are mainly attained through enhanced drug targeting and enhancements in functionality and potency. Thus, the plasma protein therapeutics market is expected to experience tremendous growth in the near future.

North America was observed as the largest plasma protein therapeutics market due to the rising prevalence of chronic diseases, high acceptance and accessibility of novel drug therapy, and mounting investments in the R&D of plasma protein therapeutics. Asia Pacific was observed as the fastest-growing plasma protein therapeutics market due to rising demand for novel therapeutics, developing healthcare infrastructure, and the rising prevalence of cancer and autoimmune diseases.

New plasma-derived therapies entering the market are on the rise, which is the major factor assisting the overall market’s growth. On the other hand, major market restraints include stringent regulatory policies, evolving reimbursement policies for the developing plasma protein therapeutics industry, and intricacy in manufacturing.

The plasma protein therapeutics market is segmented on the following basis:


  • Immunoglobulins
  • Albumin
  • Coagulation Factors
  • Alpha-1 Proteinase Inhibitor
  • Other medications (C1-esterase Inhibitors and Hyperimmune Globulins)

Pipeline Analysis

  • Analysis of Phase III Drugs, Forecast to 2026
  • Phase II and Phase I (Tabular Representation)


  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic thrombocytopenic purpura
  • Secondary Immunodeficiency
  • Others (Kawasaki disease, hereditary angioedema, GBS, and CIDP)


  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Key players identified for the plasma protein therapeutics market include:

Baxter International, GRIFOLS, S.A., Biotest, CSL Behring, Kedrion, Shire Plc., Octapharma USA, Inc., Telecris, and China Biologics

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

This report offers the following:

  • The market assessment is done by furnishing the market size and compounded annual growth rate, considering 2017 as the base year and the period from 2018 to 2026 as the forecast period.
  • For the geography, product, and application segments, an attractive investment proposition is given, which helps biopharmaceutical manufacturers to contemplate useful financial decisions.
  • The competitive landscape helps in determining the competitive milieu currently existing in the plasma protein therapeutics market.
  • The financial health of leading players is considered in the financial information segment, and a diverse range of plasma proteins is covered in the product portfolio section. Recent news coverage keeps us informed regarding the latest strategic developments and their impact on the plasma protein therapeutics market.

Frequently Asked Question:

What is the size of Plasma Protein Therapeutics Market?

The market for Plasma Protein Therapeutics Market is expected to reach USD$ XX billion in 2026.

What is the Plasma Protein Therapeutics Market CAGR?

The Plasma Protein Therapeutics Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Plasma Protein Therapeutics Market?

The report is forecasted from 2018 -2026.

What is the base year considered for Plasma Protein Therapeutics Market?

The base year of this report is 2017.

Who are the major players in this market?

Baxter International, GRIFOLS, S.A., Biotest, CSL Behring, Kedrion, Shire Plc., Octapharma USA, Inc., Telecris. are some of the major players in the global market.

Antineoplastic Agents Market

Report ID: 36065

US Retail Pharmacy Market

Report ID: 32801

OTC Vitamins Dietary Supplements Market

Report ID: 35994

Liposomes Market

Report ID: 35888

UK Iron Supplement Market

Report ID: 35709

U.S. Iron Supplement Market

Report ID: 35688

Malignant Ascites Market

Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Report ID: 2939

Combination Therapies In Aesthetics Market

Report ID: 35434

CAR T-Cell Therapy Market

Report ID: 2051

OTC Cough Cold And Allergy Medicine Market

Report ID: 20062

Purchase Options

Delivery Format: Excel.
Designed for the individual purchaser.
Users located at a single corporate site or regional office.
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 6232 49 3207


24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN